Rambhadram Biotech Profile
Key Indicators
- Authorised Capital ₹ 5.20 M
- Paid Up Capital ₹ 5.20 M
- Company Age 7 Year, 6 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.80 M
- Revenue Growth %
- Profit Growth -285.26%
- Ebitda -285.26%
- Net Worth 1122.77%
- Total Assets 150.41%
About Rambhadram Biotech
Rambhadram Biotech Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 February 2018 (Seven years 6 days old ). Its registered office is in Vidisha, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.20 M and a paid-up capital of Rs 5.20 M.
The company currently has active open charges totaling ₹9.80 M.
Manoj Tameshwari and Avinash Gohiya serve as directors at the Company.
Company Details
- Location
Vidisha, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24304MP2018PTC045047
- Company No.
045047
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Feb 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Rambhadram Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Tameshwari  | Director | 17-Feb-2018 | Current |
| Avinash Gohiya | Director | 07-Feb-2020 | Current |
Financial Performance of Rambhadram Biotech.
Rambhadram Biotech Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 285.26% decrease in profit. The company's net worth Soared by an impressive increase of 1122.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rambhadram Biotech?
In 2021, Rambhadram Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.80 M
₹0
Charges Breakdown by Lending Institutions
- Sidbi : 0.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Sep 2021 | Sidbi | ₹9.80 M | Open |
How Many Employees Work at Rambhadram Biotech?
Unlock and access historical data on people associated with Rambhadram Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rambhadram Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rambhadram Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
